Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-03-002608
Filing Date
2003-03-31
Accepted
2003-03-31 16:45:35
Documents
6
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d54936_10k.txt 10-K 250015
3 LICENSE AGREEMENT d03-54936_ex10p.txt EX-10.(P) 31975
4 AMENDED AND RESTATED STOCK OPTION PLAN d03-54936_ex10q.txt EX-10.(Q) 27126
5 NOTE PURCHASE AGREEMENT d03-54936_ex10s.txt EX-10.(S) 8186
6 NOTE PURCHASE AGREEMENT d03-54936_ex10t.txt EX-10.(T) 8392
7 CONSENT OF INDEPENDENT ACCOUNTANTS d03-54936_ex23a.txt EX-23.(A) 842
  Complete submission text file 0001169232-03-002608.txt   328810
Mailing Address 99 WOOD AVENUE SOUTH SUITE 301 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 301 ISELIN NJ 08830 7324529556
PHARMOS CORP (Filer) CIK: 0000713275 (see all company filings)

EIN.: 363207413 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-11550 | Film No.: 03631473
SIC: 2834 Pharmaceutical Preparations